BELEONZ Trademark

Trademark Overview


On Tuesday, December 17, 2013, a trademark application was filed for BELEONZ with the United States Patent and Trademark Office. The USPTO has given the BELEONZ trademark a serial number of 86145881. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 28, 2017. This trademark is owned by Eli Lilly and Company. The BELEONZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; Antidepressants; Diagnostic agents and substances for medical purposes; Radiopharmaceutical diagnostic prepara...
beleonz

General Information


Serial Number86145881
Word MarkBELEONZ
Filing DateTuesday, December 17, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 28, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2014

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; Antidepressants; Diagnostic agents and substances for medical purposes; Radiopharmaceutical diagnostic preparations for medical use in the diagnosis of neurodegenerative amyloid diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 2, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, August 28, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 28, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, December 18, 2016EXTENSION 5 GRANTED
Tuesday, December 13, 2016EXTENSION 5 FILED
Tuesday, December 13, 2016TEAS EXTENSION RECEIVED
Wednesday, July 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 12, 2016EXTENSION 4 GRANTED
Tuesday, June 28, 2016EXTENSION 4 FILED
Tuesday, June 28, 2016TEAS EXTENSION RECEIVED
Friday, October 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 1, 2015EXTENSION 3 GRANTED
Tuesday, September 29, 2015EXTENSION 3 FILED
Tuesday, September 29, 2015TEAS EXTENSION RECEIVED
Friday, July 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 2, 2015EXTENSION 2 GRANTED
Thursday, June 25, 2015EXTENSION 2 FILED
Thursday, June 25, 2015TEAS EXTENSION RECEIVED
Wednesday, January 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 27, 2015EXTENSION 1 GRANTED
Monday, December 8, 2014EXTENSION 1 FILED
Tuesday, January 27, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 8, 2014TEAS EXTENSION RECEIVED
Tuesday, July 22, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 27, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 27, 2014PUBLISHED FOR OPPOSITION
Wednesday, May 7, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 18, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 18, 2014ASSIGNED TO LIE
Wednesday, March 26, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 26, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, March 26, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 26, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, March 26, 2014EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 25, 2014ASSIGNED TO EXAMINER
Thursday, January 2, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 20, 2013NEW APPLICATION ENTERED IN TRAM